Metabolic Disorders Archives

Metabolic Disorders Rare Genetic Disease

December 12, 2025

Velaglucerase alfa is indicated for long-term enzyme replacement therapy (ERT) for patients with type 1…

Metabolic Disorders

November 8, 2025

Vimzim is mainly composed of the most important substance known as Elosulfase Alfa. It is…

Metabolic Disorders Rare Genetic Disease

November 4, 2025

Strensiq or asfotase alfa is indicated for the treatment of patients with perinatal/infantile- and juvenile-onset…

Metabolic Disorders

September 30, 2025

Elosulfase alfa, marketed under the brand name Vimizim™, is a recombinant form of the enzyme…

Dr. Banisetti Sravya 0

Metabolic Disorders